CAI
Caris Life Sciences Inc
NASDAQ · Biotechnology
$22.00
+0.75 (+3.53%)
Performance
1D
—
1W
-5.66%
1M
-14.06%
3M
-12.56%
6M
-35.82%
1Y
-21.43%
YTD
-18.46%
Open$21.46
Previous Close$21.25
Day High$22.37
Day Low$21.46
52W High$42.50
52W Low$21.18
Volume1.68M
Avg Volume2.78M
Market Cap6.21B
P/E Ratio—
EPS$-1.56
SectorBiotechnology
Volume Analysis
0.60x average volume
Technical Indicators
SMA 50
$26.43
Below
RSI (14)
25.5
Oversold
Analyst Ratings
Strong Buy
13 analysts
Price Target
+40.5% upside
Current
$22.00
$22.00
Target
$30.92
$30.92
$20.23
$30.92 avg
$48.05
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 418.51M | 1.64B | 1.52B |
| Net Income | -286,153,441 | 316.28M | 306.08M |
| Profit Margin | -68.4% | 19.3% | 20.1% |
| EBITDA | -261,239,865 | 415.16M | 429.14M |
| Free Cash Flow | — | 185.08M | 215.40M |
| Rev Growth | — | +14.2% | +10.8% |
| Debt/Equity | 0.79 | 0.26 | 0.28 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $223.43 | +2.01% | 165.4 | 394.89B |
| AMGN | Amgen Inc | $384.32 | +4.49% | 26.8 | 206.95B |
| GILD | Gilead Sciences Inc | $152.50 | +2.10% | 23.3 | 189.20B |
| VRTX | Vertex Pharmaceuticals Inc | $477.92 | +4.17% | 33.7 | 123.82B |
| REGN | Regeneron Pharmaceuticals | $785.51 | +2.46% | 18.4 | 83.03B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.16 | -0.93% | 995.2 | 43.35B |